Statistical communications in infectious diseases

Keyphrases

Publications

volume 15, number 1, 2024

Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)
Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)
Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)
Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)
Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)
Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)
Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)
Deborah J Donnell, Sheila Kansiime, David V Glidden, Alex Luedtke, Peter B Gilbert, Fei Gao, Holly Janes
Study design approaches for future active-controlled HIV prevention trials. Statistical communications in infectious diseases 15 (1) (2024)

volume 14, number 1, 2022

Sihaoyu Gao, Lang Wu, Tingting Yu, Roger Kouyos, Huldrych F Gunthard, Rui Wang
Nonlinear mixed-effects models for HIV viral load trajectories before and after antiretroviral therapy interruption, incorporating left censoring. Statistical communications in infectious diseases 14 (1) (2022)

volume 13, number 1, 2021

Waleed Almutiry, Rob Deardon
Contact network uncertainty in individual level models of infectious disease transmission. Statistical communications in infectious diseases 13 (1) (2021)
David T Dunn, Oliver T Stirrup, David V Glidden
Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate. Statistical communications in infectious diseases 13 (1) (2021)
Pantelis Samartsidis, Natasha N Martin, Victor De Gruttola, Frank De Vocht, Sharon Hutchinson, Judith J Lok, Amy Puenpatom, Rui Wang, Matthew Hickman, Daniela De Angelis
Evaluating the power of the causal impact method in observational studies of HCV treatment as prevention. Statistical communications in infectious diseases 13 (1) (2021)
Fei Gao, David V Glidden, James P Hughes, Deborah J Donnell
Sample size calculation for active-arm trial with counterfactual incidence based on recency assay. Statistical communications in infectious diseases 13 (1) (2021)

volume 12, number 1, 2020

Anu Mishra, Petra Buzkova, Jennifer E Balkus, Elizabeth R Brown, null null
Accounting for Informative Sampling in Estimation of Associations between Sexually Transmitted Infections and Hormonal Contraceptive Methods. Statistical communications in infectious diseases 12 (1) (2020)

volume 12, number Suppl 1, 2020

Elizabeth R Brown, Clara P Dominguez Islas, Jingyang Zhang
Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials. Statistical communications in infectious diseases 12 (Suppl 1) (2020)
Rami Kantor, John P Fulton, Jon Steingrimsson, Vladimir Novitsky, Mark Howison, Fizza Gillani, Yuanning Li, Akarsh Manne, Zoanne Parillo, Matthew Spence, Theodore Marak, Philip Chan, Casey W Dunn, Thomas Bertrand, Utpala Bandy, Nicole Alexander-Scott, Joseph W Hogan
Challenges in evaluating the use of viral sequence data to identify HIV transmission networks for public health. Statistical communications in infectious diseases 12 (Suppl 1) (2020)
Giorgos Bakoyannis, Lameck Diero, Ann Mwangi, Kara K Wools-Kaloustian, Constantin T Yiannoutsos
A semiparametric method for the analysis of outcomes during a gap in HIV care under incomplete outcome ascertainment. Statistical communications in infectious diseases 12 (Suppl 1) (2020)
Ante Bing, Yuchen Hu, Melanie Prague, Alison L Hill, Jonathan Z Li, Ronald J Bosch, Victor De Gruttola, Rui Wang
Comparison of empirical and dynamic models for HIV viral load rebound after treatment interruption. Statistical communications in infectious diseases 12 (Suppl 1) (2020)

volume 12, number Suppl1, 2020

Bryan E Shepherd, Pamela A Shaw
Errors in multiple variables in human immunodeficiency virus (HIV) cohort and electronic health record data: statistical challenges and opportunities. Statistical communications in infectious diseases 12 (Suppl1) (2020)
Allan Kimaina, Jonathan Dick, Allison DeLong, Stavroula A Chrysanthopoulou, Rami Kantor, Joseph W Hogan
Comparison of machine learning methods for predicting viral failure: a case study using electronic health record data. Statistical communications in infectious diseases 12 (Suppl1) (2020)
Andrea S Foulkes, Livio Azzoni, Luis J Montaner
Pre-selected class-level testing of longitudinal biomarkers reduces required multiple testing corrections to yield novel insights in longitudinal small sample human studies. Statistical communications in infectious diseases 12 (Suppl1) (2020)

volume 11, number 1, 2019

David T Dunn, David V Glidden
The Connection between the Averted Infections Ratio and the Rate Ratio in Active-control Trials of Pre-exposure Prophylaxis Agents. Statistical communications in infectious diseases 11 (1) (2019)
Peter B Gilbert
Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial Designs. Statistical communications in infectious diseases 11 (1) (2019)
David V Glidden
Advancing Novel PrEP Products - Alternatives to Non-Inferiority. Statistical communications in infectious diseases 11 (1) (2019)
Thomas R Fleming, Victor DeGruttola, Deborah Donnell
Designing & Conducting Trials To Reliably Evaluate HIV Prevention Interventions. Statistical communications in infectious diseases 11 (1) (2019)

volume 10, number 1, 2018

Scott Evans, Daniel B Rubin, John H Powers, Dean Follmann
Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze? Statistical communications in infectious diseases 10 (1) (2018)
Doug Morrison, Oliver Laeyendecker, Jacob Konikoff, Ron Brookmeyer
Cross-Sectional HIV Incidence Estimation with Missing Biomarkers. Statistical communications in infectious diseases 10 (1) (2018)

volume 9, number 1, 2017

Reshma Kassanjee, Daniela De Angelis, Marian Farah, Debra Hanson, Jan Phillipus Lourens Labuschagne, Oliver Laeyendecker, Stéphane Le Vu, Brian Tom, Rui Wang, Alex Welte
Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the 'Mean Duration of Recent Infection'. Statistical communications in infectious diseases 9 (1) (2017)
Peter B Gilbert, Michal Juraska, Allan C deCamp, Shelly Karuna, Srilatha Edupuganti, Nyaradzo Mgodi, Deborah J Donnell, Carter Bentley, Nirupama Sista, Philip Andrew, Abby Isaacs, Yunda Huang, Lily Zhang, Edmund Capparelli, Nidhi Kochar, Jing Wang, Susan H Eshleman, Kenneth H Mayer, Craig A Magaret, John Hural, James G Kublin, Glenda Gray, David C Montefiori, Margarita M Gomez, David N Burns, Julie McElrath, Julie Ledgerwood, Barney S Graham, John R Mascola, Myron Cohen, Lawrence Corey
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Statistical communications in infectious diseases 9 (1) (2017)
Scott R Evans, John Powers
Evaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls? Statistical communications in infectious diseases 9 (1) (2017)

volume 3, number 1, 2011

Amalia S Magaret, Jeffrey Stanaway
Sample Size for a Binomial Proportion with Autocorrelation. Statistical communications in infectious diseases 3 (1) (2011)
Elaine O Nsoesie, Richard Beckman, Madhav Marathe, Bryan Lewis
Prediction of an Epidemic Curve: A Supervised Classification Approach. Statistical communications in infectious diseases 3 (1) (2011)